Retinal and choroidal changes with severe hypertension and their association with visual outcome

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 12, 2014, Pages 7775-7785

  Ahn, Seong Joon ^a,b   Woo, Se Joon ^a   Park, Kyu Hyung ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b The Armed Forces Capital Hospital   (South Korea)

Author keywords

Choroid; Hypertension; Optical coherence tomography; Retina

Indexed keywords

ADULT; ARTICLE; CENTRAL MACULAR THICKNESS; CHOROID; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; MACULAR EDEMA; MALE; MEAN ARTERIAL PRESSURE; OPHTHALMOSCOPY; RETINA; RETINAL NERVE FIBER LAYER THICKENING; SLIT LAMP; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBFOVEAL CHOROIDAL THICKNESS; SUBRETINAL FLUID HEIGHT; SYSTOLIC BLOOD PRESSURE; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS; CHOROID DISEASES; COMPLICATION; EXUDATE; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; RETINAL DISEASES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; CHOROID DISEASES; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; YOUNG ADULT;

EID: 84915750098     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14915     Document Type: Article

References (34)

1. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1988; 148: 1023-1038.
2. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25: 305-313.
3. Julius S. Current trends in the treatment of hypertension: a mixed picture. Am J Hypertens. 1997; 10: 300S-305S.
4. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206-1252.
5. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007; 25: 1751-1762.
6. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004; 18: 139-185.
7. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci. 1939; 197: 332-343.
8. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004; 351: 2310-2317.
9. Hammond S, Wells JR, Marcus DM, Prisant LM. Ophthalmoscopic findings in malignant hypertension. J Clin Hypertens (Greenwich). 2006; 8: 221-223.
10. Tso MO, Jampol LM. Pathophysiology of hypertensive retinopathy. Ophthalmology. 1982; 89: 1132-1145.
11. Hayreh SS, Servais GE, Virdi PS. Fundus lesions in malignant hypertension. IV. Focal intraretinal periarteriolar transudates. Ophthalmology. 1986; 93: 60-73.
12. Kishi S, Tso MO, Hayreh SS. Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy. Arch Ophthalmol. 1985; 103: 1189-1197.
13. Suzuki M, Minamoto A, Yamane K, Uka J, Aoki S, Mishima HK. Malignant hypertensive retinopathy studied with optical coherence tomography. Retina. 2005; 25: 383-384.
14. Takahashi A, Nagaoka T, Yoshida A. Stage 1-A macular hole: a prospective spectral-domain optical coherence tomography study. Retina. 2011; 31: 127-147.
15. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008; 146: 496-500.
16. Sim DA, Keane PA, Mehta H, et al. Repeatability and reproducibility of choroidal vessel layer measurements in diabetic retinopathy using enhanced depth optical coherence tomography. Invest Ophthalmol Vis Sci. 2013; 54: 2893-2901.
17. Esmaeelpour M, Povazay B, Hermann B, et al. Threedimensional 1060-nm OCT: choroidal thickness maps in normal subjects and improved posterior segment visualization in cataract patients. Invest Ophthalmol Vis Sci. 2010; 51: 5260-5266.
18. Ikuno Y, Kawaguchi K, Nouchi T, Yasuno Y. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci. 2010; 51: 2173-2176.
19. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010; 150: 325-329, e321.
20. Kerenyi T, Jellinek H, Huttner I, Goracz G, Konyar E. Fibrinoid necrosis of the vascular wall in experimental malignant hypertension. Acta Morphol Acad Sci Hung. 1966; 14: 175-182.
21. Wolfgarten M, Magarey FR. Vascular fibrinoid necrosis in hypertension. J Pathol Bacteriol. 1959; 77: 597-603.
22. Baumuller S, Charbel Issa P, Scholl HP, Schmitz-Valckenberg S, Holz FG. Outer retinal hyperreflective spots on spectraldomain optical coherence tomography in macular telangiectasia type 2. Ophthalmology. 2010; 117: 2162-2168.
23. Kinyoun JL, Kalina RE. Visual loss from choroidal ischemia. Am J Ophthalmol. 1986; 101: 650-656.
24. Patel N, Riordan-Eva P, Chong V. Persistent visual loss after retinochoroidal infarction in pregnancy-induced hypertension and disseminated intravascular coagulation. J Neuroophthalmol. 2005; 25: 128-130.
25. Ugarte M, Horgan S, Rassam S, Leong T, Kon CH. Hypertensive choroidopathy: recognizing clinically significant end-organ damage. Acta Ophthalmol. 2008; 86: 227-228.
26. Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol. 1967; 63(suppl): 1-139.
27. Scheider A, Nasemann JE, Lund OE. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol. 1993; 115: 50-56.
28. Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2011; 151: 594-603, e591.
29. Moorthy RS, Lyon AT, Rabb MF, Spaide RF, Yannuzzi LA, Jampol LM. Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology. 1998; 105: 1380-1385.
30. Ojima Y, Hangai M, Sasahara M, et al. Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology. 2007; 114: 2197-2207.
31. Wakabayashi T, Oshima Y, Fujimoto H, et al. Foveal microstructure and visual acuity after retinal detachment repair: imaging analysis by Fourier-domain optical coherence tomography. Ophthalmology. 2009; 116: 519-528.
32. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. Arch Ophthalmol. 1953; 49: 117-138.
33. Ong YT, Wong TY, Klein R, et al. Hypertensive retinopathy and risk of stroke. Hypertension. 2013; 62: 706-711.
34. Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012; 53: 261-266.